SciELO - Scientific Electronic Library Online

 
vol.69The Synthesis of Carbon Nanomaterials using Chlorinated Hydrocarbons over a Fe-Co/CaCO3 CatalystLack of Co-crystal Formation with Cyclotriphosphazenes: A Cautionary Tale author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Article

Indicators

Related links

  • On index processCited by Google
  • On index processSimilars in Google

Share


South African Journal of Chemistry

On-line version ISSN 1996-840X
Print version ISSN 0379-4350

S.Afr.j.chem. (Online) vol.69  Durban  2016

http://dx.doi.org/10.17159/0379-4350/2016/v69a4 

RESEARCH ARTICLE

 

Oxyhalogen-Sulfur Chemistry: Kinetics and Mechanism of Oxidation of N-acetylthiourea by Aqueous Bromate and Acidified Bromate

 

 

Kudzanai ChipisoI; Wilbes MbiyaI; Thai TranI; Reuben H. SimoyiI, II, *

IDepartment of Chemistry, Portland State University, Portland, OR 97207-0751, USA
IISchool of Chemistry and Physics, University of KwaZulu-Natal, Westville Campus, Durban 4014. South Africa

 

 


ABSTRACT

The oxidation of N-acetylthiourea (ACTU) by acidic bromate has been studied by observing formation of bromine in excess bromate conditions. The reaction displays an induction period before formation of bromine. The stoichiometry of the reaction was determined to be 4:3:4BrO3- + 3(CH3CO)NH(NH2)C=S + 3H2O > 4Br- + 3(CH3CO)NH(NH2)C=O + 3SO42- + 6H+ (A) witha complete desulfurization of ACTU to its urea analogue. In excess bromate conditions the stoichiometry was 8:5: 8BrO3- + 5(CH3CO)NH(NH2)C=S + H2O > 4Br2 + 5(CH3CO)NH(NH2)C=O + 5SO42- + 2H+ (B). Bromine is derived from an extraneous reaction in which bromide from stoichiometry (A) reacts with excess acidic bromate. The oxidation of ACTU by aqueous bromine gave stoichiometry (C):4Br2(aq) + (CH3CO)NH(NH2)C=S + 5H2O > 8Br- + (CH3CO)NH(NH2)C=O + SO42- + 10H+. Reaction (C) is much faster than reactions (A) and (B), with a lower limit bimolecular rate constant of 2.1 X105 M-1 s-1 such that appearance of bromine signals complete consumption of ACTU. We were unable to trap any intermediate sulfur oxo-acids of ACTU on its oxidation pathway to N-acetylurea. As opposed to other substituted thioureas, none of its intermediates were stable enough to be isolated and detected.

Keywords: Kinetics, mechanisms, oxyhalogen chemistry, s-oxygenation, bioactivation.


 

 

1. Introduction

The chemistry of thiourea and its derivatives has received considerable attention because of its important applications in synthesis of biologically-active compounds. They form the backbone in structures of these drugs and the biological activities of most of the thiourea-derived drugs depend on the existence of the thiourea moiety.1 Thiourea and its derivatives are thus a vast group of very active biological molecules.2-8 Major pathway to their bioactivation is oxidative and specifically via S-oxygenation in which there is a successive addition of oxygen to the sulfur center until oxidative saturation is attained at sulfate.9-11 Small molecule thioureas are oxygenated predominantly by catalysis from the flavin-containing monooxygenases12,13 to form reactive sulfenic acids that reversibly react with glutathione14-19 to drive oxidative stress through a redox cycle. The higher molecular weight versions tend to be metabolized by the CYP450 system of enzymes.20-22 There is a new thrust in medicinal chemistry that involves substituted thioureas as therapeutic drugs for several diseases.23 No other pharmacophore possesses such a wide range of biological activity. For example, comparatively, the 4-aminoquinoline pharmacophore has been exploited in a variety of ways to derive antimalarials24-26, but it is exclusively for one disease and has not found significant use for any other disease. The ease of synthesis of substituted thioureas27-33 means that there are now hundreds of these analogues available which have not yet been characterized.7,34 Although effective, drugs containing the thiourea functional group have been found to exhibit some toxicity. Methimazole, for example, an antithyroid drug used in the treatment of hyperthyroidism and Graves Disease, has been associated with idiosyncratic toxicity, characterized by skin reactions, leucopenia, agranulocytosis, aplastic anemia, hepatitis and cholestasis.35,36 The relationship between idiosyncratic adverse reactions and reactive metabolites is not well established. There is circumstantial evidence, however, that reactive metabolites are involved in the onset of idiosyncratic adverse reactions.37,38 Sulfur atom has been thought to be the site of bioactivation of these organosulfur compounds resulting in conceivably toxic metabolites.39 Biological oxidations of small molecules such as N-acetylthiourea, N-methylthiourea show that sulfur is a soft nucleophile, and is easily oxidized by oxi-dants such as iodine, HOBr and HOCl, which are found in the physiological environment albeit in low concentrations.40 The difference in oxidative environment and oxidizing species has a large bearing on the intermediates and subsequent products. Although there are similarities in the oxidation patterns displayed by these small molecules, they is no generic pathway for their oxidation. Kinetics and mechanistic studies of N-acetyl thiourea (ACTU) with chlorite, showed complex behaviour41 which is different from the behaviour displayed when unsubstituted thiourea is oxidized by chlorite in acidic medium.42

N-acetylthiourea and its derivatives serve as highly potent and isozyme selective activators for the recombinant form of human histone deacetylase-8 in the assay system containing fluor-de-lys as a fluorescent substrate.43 This is an activity not manifested by the parent thiourea. We report, in this manuscript, on the oxidation mechanism of ACTU by acidic bromate and aqueous bromine. Its oxidation mechanism can be correlated with its physiological effect.

 

2. Experimental Procedures

2.1. Materials

The following reagent grade chemicals were used without further purification: sodium bromate, perchloric acid (70-72 %), sodium bromide, bromine, sodium perchlorate, soluble starch, sodium thiosulfate (Fisher), and ACTU (Sigma). Bromine solutions, being volatile, were kept capped and standardized spectropho-tometrically before each set of experiments. Stock solutions of N acetyl thiourea were prepared just before use.

2.2. Methods

The rapid reactions of ACTU with bromine were followed on a Hi-Tech Scientific SF61-DX2 double-mixing stopped-flow spectrophotometer. These reactions were monitored by following formation of bromine at 390 nm (e = 142 M-1 cm-1). ACTU has no absorbance in the visible region, while aqueous bromine has an isolated peak at 390 nm. Thus absorbance at this peak was used for analytical determination of aqueous bromine. Slower reactions involving N-acetylurea formation following oxidation of ACTU by acidified bromate were monitored on a conventional Perkin-Elmer Lambda 25 UV-Vis spectrophotometer. All kinetics experiments were performed at 25.0 ± 0.1 °C and at an ionic strength of 1 M (NaClO4). All solutions were prepared using doubly-distilled deionized water from a Barnstead Sybron Corporation water purification unit capable of producing both distilled and deionized water (Nanopure). Mass spectra of product solutions were taken on a Thermo Scientific LTQ-Orbitrap XL Discovery mass spectrometer (San Jose, CA) equipped with an electrospray ionization source operated in the positive mode.

 

3. Results

3.1. Stoichiometry

The stoichiometry in excess acidic bromate was determined spectrophotometrically using the bromine absorbance at 390 nm. Figure 1 shows the combined spectra of ACTU, aqueous bromine and product solution at excess bromate conditions. ACTU has no absorbance in the visible region, and thus the aqueous bromine peak at 390 nm is isolated and can be used for analytical determination of bromine at the end of the reaction. This spectrophotometric method worked for a limited range of oxidant to reductant ratios; R = [BrO3-]0/[ACTU]0. At values of R greater than 1.6; the observed final absorbance of bromine saturated, and further increases in oxidant did not produce any changes in observed final bromine concentrations. In excess ACTU conditions, the stoichiometry was determined titrimetrically by utilizing excess oxidant and determining residual oxidizing power for a fixed amount of ACTU and varying acidic bromate.

Figure 2 shows the iodometric titration utilized for the determination of the stoichiometry of the reaction in excess reductant, though the determination was performed in excess oxidant. These titrimetric determinations were performed in triplicates. The titre varied linearly with increase in bromate concentrations. A plot of titre vs bromate concentrations for a fixed amount of [ACTU]0 of 1.0 mM gave a straight line with an intercept of 1.33 mM (= 4/3). This intercept value represents the amount of bromate needed to just completely oxidize 1.0 mM with no excess bromate left to form bromine which will result in a titre against thiousulfate. The stoichiometry is thus solidly 4:3:

Spectrophotometric determination in excess bromate conditions gave a stoichiometry of 8:5:

At high excess of bromate, amount of bromine formed was determined by initial concentrations of ACTU. This can be seen in Fig. 6 (vide infra).

98% of the sulfur in ACTU was gravimetrically analyzed as sulfate. One important reaction in the reaction mixture is the direct oxidation of ACTU by aqueous bromine. The stoichiometry was determined titrimetrically, as shown in Fig. 2b, by titrating bromine in aqueous iodine enhanced by soluble starch. The stoichiometry was determined to be 4:1:

3.2. Kinetics

In excess acidic bromate, the reaction showed a monotonic increase in absorbance of aqueous bromine after a short induction period. No other active absorbance peaks were observed (see Fig. 3).

No bromine formation was observed when oxidant to reductant ratio was less than 1.33, i.e. stoichiometry R1. This indicates that reaction of bromine and ACTU is so rapid that these two cannot coexist on the time scale of reaction R1.

All kinetics traces shown in Figures 4 to 7 were obtained in triplicates. The reaction is strongly catalyzed by acid (see Fig. 4). Acid, however, is not a reactant in the reaction under study, but it decreases the quiescent period before commencement of bromine formation and also rapidly increases the rate of formation bromine after the induction period. Generally, there was an inverse square dependence of the induction period with acid over a limited range of acid concentrations. This effect tailed off and became an inverse first-order dependence at high acid concentrations. The formation of bromine, however, was strongly second order in acid. The reaction was run in highly excess acid conditions such that it could be assumed that acid concentrations remained invariant over the lifetime of the reaction; i.e. essentially buffered. None of the other reagents' concentrations, [BrO3-]t, [ACTU]t could be determined at the onset of formation of bromine such that no relevant kinetics constants could be evaluated for the rate of formation of bromine. Acid did not alter final amount of bromine obtained based on stoichiometry R2, but accelerated the rate of attainment of the final bromine concentrations.

Figure 5 shows the effect of bromate concentrations on the reaction. In this case, induction period has an inverse dependence on initial bromate concentrations and a linear dependence on rate of formation of bromine after the induction period. For all the scans in Fig. 5 the oxidant reductant ratios were greater than 1.6. The different bromate concentrations, provided that the oxidant to reductant ratios were greater than 1.6, did not alter the final amount of bromine formed. Figure 6 shows the effect of ACTU concentrations at constant acid and bromate concentrations. All these experiments were performed at oxidant to reductant ratios greater than 1.6 (reaction R2) and thus the amount of final bromine formed is determined by [ACTU]0. Final bromine concentrations were 0.80[ACTU]0 according to reaction R2 stoichiometry. At these conditions of high ratios, the induction period was invariant with rate of formation of bromine obeying a first order dependence on [ACTU]0. No ACTU is available at the commencement of bromine formation (Reaction R3 is fast), and so formation of bromine is dependent on reactive species derived from the oxidation of ACTU.

Figure 7 shows spectrophotometric traces of the direct Br2 -ACTU reaction. They were all run in stoichiometric excess of bromine such that there is residual bromine at the end of the reaction. A plot of residual absorbance vs [Br2]0 gave an intercept value that corroborates stoichiometry R3 (plot not shown) This intercept value indicates the concentration of bromine needed to just completely oxidize the ACTU concentration utilized in all the series of experiments (0.90 mM). The reaction is nearly diffusion-controlled and is faster than the mixing time of our stopped-flow apparatus of 1 ms. The reaction is first order in both bromine and ACTU. Due to the imprecision in the kinetics measurements, we could only evaluate a lower-limit bimolecular rate constant of 2.1 x105 M-1 s-1 (no error bars since this represents a lower limit value).

 

4. Mechanism

The reaction of the unsubstituted thiourea was studied by Simoyi et al.44in 1994. The remarkable difference is that reaction of ACTU is much faster. This would suggest that ACTU is unable to stabilize any intermediates on its oxidation pathway to product N-acetylurea. We ran different stoichiometric ratios of oxidant to reductant and obtained the ESI spectra of the final product in each case. In excess oxidant, the only peak obtained was for the product at m/z = 103.05. Figure 8 shows the ESI spectrum of a reaction solution in which the reductant, ACTU, is in stoichiometric excess. Any intermediates that can be stabilized should be detected in this environment. Only the unreacted substrate, at m/z = 119.03 and the product are observed. The expected peak for a possible sulfinic acid, m/z = 135.03 is not observed. Neither is a possible sulfonic acid at m/z = 151.03 observed. Another substituted thiourea, tertamethylthiourea, has shown all possible oxo-acid intermediates before formation of product tetramethylurea.45

Thus the mechanism involves simply the expected oxybromine kinetics.46 Rate-determining step is the initial oxidation of ACTU; subsequent oxidations of the intermediates to N-acetylurea are facile. The rate of the overall reaction conforms to the rate law:

In Equation (1), Red can be any 2-electron reductant. Involvement of acid is through protonation of bromate to bromic acid; followed by the acidification of bromic acid to produce the active oxidizing species:

With reaction R6 as the rate-determining step, then overall rate law Equation (1) can be justified. Standard oxybromine kinetics involve Br- as the 2-electron reductant which is oxidized to HOBr:

If sequence R4 to R8 is correct, according to the standard oxybromine kinetics, then oxidation of the sulfur center should proceed through 2-electron oxidations via sulfenic (S(I)), sulfinic (S(II)) and sulfonic (S(IV)) acids. This is a sequence that has been suggested in several oxidations of thiols and thiocarbamides.47

Thus the initial oxidation of ACTU would be by the generated reactive species HOBr:

((CH3CO)NH)(NH2)C-SOH is the expected unstable sulfenic acid which should subsequently be rapidly oxidized further to the sulfinic acid and sulfonic acids:

Cleavage of the C-S bond should occur on oxidation of the sulfonic acid:

With HOBr as the major oxidizing species, then observed rate law (1) will hold in the form of (2) through reaction R8:

Initial bromide concentrations to initiate reaction R8 are derived from a direct reaction of bromic acid with ACTU:

Followed by reaction R10. The trace amounts of bromide formed in R10 are amplified through reaction R8.

 

5. Conclusion

This short mechanistic study has shown that despite similarities in thioureas, their oxidations can differ wildly. ACTU is unable to generate stable sulfur oxo-acids on the pathway towards formation of product N-acetylurea. Thus it is much more easily oxidized that the parent thiourea and other substituted thioureas such as trimethyl- and tetramethylthiourea.

 

Acknowledgements

This research work was supported by Grant Number CHE 1056311 from the National Science Foundation and a partial research professor vote from the University of KwaZulu-Natal.

 

References

1 O.J. D'Cruz, T.K. Venkatachalam and F.M. Uckun, Novel thiourea compounds as dual-function microbicides. Biol. Reproduction, 2000, 63,196-205.         [ Links ]

2 Y. Dong, T. K. Venkatachalam, R.K. Narla, V.N.Trieu, E.A. Sudbeck and F.M. Uckun, Antioxidant function of phenethyl-5-bromo-pyridyl thiourea compounds with potent anti-HIV activity. Bioorg. Med. Chem. Lett, 2000, 10, 87-90.         [ Links ]

3 L.C. Eiter, N.W. Hall, C.S. Day, G. Saluta, G.L. Kucera and U. Bierbach, Gold(I) analogues of a platinum-acridine antitumor agent are only moderately cytotoxic but show potent activity against Mycobacterium tuberculosis, J. Med. Chem., 2009, 52, 6519-6522.         [ Links ]

4 S. Saeed, N. Rashid, P.G. Jones, M. Ali and R. Hussain, Synthesis, characterization and biological evaluation of some thiourea derivatives bearing benzothiazole moiety as potential antimicrobial and anticancer agents, Eur. J. Med. Chem., 2010, 45, 1323-1331.         [ Links ]

5 M. Struga, S. Rosolowski, J. Kossakowski and J. Stefanska, Synthesis and microbiological activity of thiourea derivatives of 4-aza- tricyclo[5.2.2.0(2,6)]undec-8-ene-3,5-dione, Arch. Pharm. Res., 2010, 33, 47-54.         [ Links ]

6 M. Struga, J. Kossakowski, A.E. Koziol, et al. Synthesis, pharmacological and antiviral activity of 1,3-thiazepine derivatives, Eur. J. Med. Chem., 2009, 44, 4960-969.         [ Links ]

7 I. Kucukguzel, E. Tatar, S.G. Kucukguzel, S. Rollas and E. De Clercq, Synthesis of some novel thiourea derivatives obtained from 5-[4-aminophenoxy)methyl]-4-alkyl/aryl-2,4-dihydro-3H-1,2,4-tria- zole-3-thiones and evaluation as antiviral/anti-HIV and antituberculosis agents, Eur. J. Med. Chem., 2008, 43, 381-392.         [ Links ]

8 R.S. Upadhayaya, G.M. Kulkarni, N.R. Vasireddy, et al., Design, synthesis and biological evaluation of novel triazole, urea and thiourea derivatives of quinoline against Mycobacterium tuberculosis, Bioorg. Med. Chem., 2009,17,4681-692.         [ Links ]

9 L.L. Poulsen, R.M. Hyslop and D.M. Ziegler., S-Oxygenation of N-substituted thioureas catalyzed by the pig liver microsomal FAD-containing monooxygenase, Arch. Biochem. Biophys., 1979, 198, 78-88.         [ Links ]

10 S.A. Svarovsky, R.H. Simoyi and S.V. Makarov, Reactive oxygen species in aerobic decomposition of thiourea dioxides, J. Chem. Soc. - Dalton Transactions, 2000, 511-514.         [ Links ]

11 K. Ziegler-Skylakakis, S. Nill, J.F. Pan and U. Andrae, S-oxygenation of thiourea results in the formation of genotoxic products, Environ. Mol. Mutagen., 1998, 31, 362-373.         [ Links ]

12 M.C. Henderson, S.K. Krueger, J.F. Stevens and D.E. Williams, Human flavin-containing monooxygenase form 2 S-oxygenation: sulfenic acid formation from thioureas and oxidation of glutathione, Chem. Res. Toxicol., 2004,17, 633-640.         [ Links ]

13 S.K. Krueger, S.R. Martin, M.F. Yueh, C.B. Pereira and D.E. Williams, Identification of active flavin-containing monooxygenase isoform 2 in human lung and characterization of expressed protein, Drug Metab. Dispos., 2002, 30, 34-1.         [ Links ]

14 J.K. Beck, S. Ambahera, S.R. Yong, M.M. Sheil, J. de Jersey and S.F. Ralph, Direct observation of covalent adducts with Cys34 of human serum albumin using mass spectrometry, Anal. Biochem., 2004, 325, 326-336.         [ Links ]

15 M. Johansson and M. Lundberg, Glutathionylation of beta-actin via a cysteinyl sulfenic acid intermediary, BMC Biochem., 2007, 8, 26.         [ Links ]

16 Ma L.H., Takanishi C.L. and Wood M.J., Molecular mechanism of oxidative stress perception by the Orp1 protein, J. Biol. Chem., 2007, 282, 31429-31436.         [ Links ]

17 L. Turell, H. Botti, S. Carballal, R. Radi and B. Alvarez, Sulfenic acid - A key intermediate in albumin thiol oxidation, J. Chromatog. B - Analytical Technologies in the Biomedical and Life Sciences, 2009, 877, 3384-3392.         [ Links ]

18 L. Turell, S. Carballal, H. Botti, R. Radi and B. Alvarez, Oxidation of the albumin thiol to sulfenic acid and its implications in the intravascular compartment, Braz. J. Med. Biol. Res. 2009, 42, 305-311.         [ Links ]

19 L. Turell, H. Botti, S. Carballal, et al., Reactivity of sulfenic acid in human serum albumin, Biochemistry, 2008, 47, 358-367.         [ Links ]

20 S.G. Kim, H.J. Kim and C.H. Yang, Thioureas differentially induce rat hepatic microsomal epoxide hydrolase and rGSTA2 irrespective of their oxygen radical scavenging effect: effects on toxicant-induced liver injury, Chem. Biol. Interact., 1999,117, 117-134.         [ Links ]

21 G.J. Stevens, K. Hitchcock, Y.K. Wang, et al., In vitro metabolism of N-(5-chloro-2-methylphenyl)-N'-(2-methylpropyl)thiourea: species comparison and identification of a novel thiocarbamide-glutathione adduct, Chem. Res. Toxicol., 1997,10, 733-741.         [ Links ]

22 R.S. Obach, A.S. Kalgutkar, T.F. Ryder and G.S. Walker, In vitro metabolism and covalent binding of enol-carboxamide derivatives and anti-inflammatory agents sudoxicam and meloxicam: insights into the hepatotoxicity of sudoxicam, Chem. Res. Toxicol., 2008, 21, 1890-1899.         [ Links ]

23 C.H. Andrade, K.F. Pasqualoto, E.I. Ferreira and A.J. Hopfinger, Rational design and 3D-pharmacophore mapping of 5'-thiourea-substituted alpha-thymidine analogues as mycobacterial TMPK inhibitors, . J. Chem. Inf. Model., 2009, 49, 1070-1078.         [ Links ]

24 C.B. Davis, R. Bambal, G.S. Moorthy, et al., Comparative preclinical drug metabolism and pharmacokinetic evaluation of novel 4-aminoquinoline anti-malarials, J. Pharm. Sci., 2009, 98, 362-377.         [ Links ]

25 P.M. O'Neill, P.G. Bray, S.R. Hawley, S.A. Ward and B.K. Park, 4-Aminoquinolines - past, present, and future: a chemical perspective, Pharmacol. Ther. 1998, 77, 29-58.         [ Links ]

26 P.M. O'Neill, D.J. Willock, S.R. Hawley, et al., Synthesis, antimalarial activity, and molecular modeling of tebuquine analogues, J. Med. Chem. 1997,40, 437-48.         [ Links ]

27 H.Q. Li, T. Yan, Y. Yang, L. Shi, C.F. Zhou and H. L. Zhu, Synthesis and structure-activity relationships of N-benzyl-N-(X-2-hydroxy- benzyl)-N'-phenylureas and thioureas as antitumor agents. Bioorg. Med. Chem., 2010, 18, 305-313.         [ Links ]

28 P.C. Lv, C.F. Zhou, J. Chen, et al., Design, synthesis and biological evaluation of thiazolidinone derivatives as potential EGFR and HER-2 kinase inhibitors, Bioorg. Med. Chem. 2010; 18: 314-319.         [ Links ]

29 B. Pan, R. Z. Huang, S.Q. Han, et al., Design, synthesis, and antibiofilm activity of 2-arylimino-3-aryl-thiazolidine-4-ones, Bioorg. Med. Chem. Letters, 2010, 20, 2461-2464.         [ Links ]

30 Y. Qian, G.Y. Ma, Y. Yang, et al., Synthesis, molecular modeling and biological evaluation of dithiocarbamates as novel antitubulin agents, Bioorg. Med. Chem., 2010,18, 4310-316.         [ Links ]

31 K.X. Chen, Z.G. Li, H.Y. Xie and J.R. Gao, Quantitative structure-activity relationship studies on some novel anti-HIV thiourea derivatives with cytotoxicity data (CC50) in MT-4 Cells, Lett. Drug Des. Disc., 2009, 6, 193-200.         [ Links ]

32 Z.G. Li, K.X. Chen, H.Y. Xie and J.R. Gao, Quantitative structure -Activity relationship analysis of some thiourea derivatives with activities against HIV-1 (IIIB), Qsar & Combinatorial Science, 2009, 28, 89-97.         [ Links ]

33 P.H. Gawade , P.Y. Pawar, B.K. Karale and S.S. Rindhe, Synthesis and antimicrobial screening of substituted thiocarbamido arylamino-thiazoles, Ind. J. Heterocyclic Chem., 2009, 19, 85-86.         [ Links ]

34 M. Park and T.C. Bruice, Development of potential anticancer agents that target the telomere sequence, Bioorg. Med. Chem. Letters, 2010,20, 3982-3986.         [ Links ]

35 F. Otsuka, J.Y. Noh, T. Chino, et al., Hepatotoxicity and cutaneous reactions after antithyroid drug administration, Clinical Endocrinology, 2012, 77, 310-315.         [ Links ]

36 S.A. Rivkees and A. Szarfman, Dissimilar hepatotoxicity profiles of propylthiouracil and methimazole in children, J. Clin. Endocr. Metab., 2010, 95, 3260-3267.         [ Links ]

37 J.P. Uetrecht, Reactive metabolites and idiosyncratic toxicity, Drug Metab. Rev., 2006, 38, 35-36.         [ Links ]

38 J. Uetrecht, Idiosyncratic drug reactions: past, present, and future, Chem. Res. Toxicol., 2008, 21, 84-92.         [ Links ]

39 F.I. Zuniga, D. Loi, K.H.J. Ling and D.D.S. Tang-Lin, Idiosyncratic reactions and metabolism of sulfur-containing drugs, Exp. Opin. Drug Metab. Toxicol. 2012, 8, 467485.         [ Links ]

40 K.M. Toth, J.M. Harlan, C.J. Beehler, et al., Dimethylthiourea prevents hydrogen peroxide and neutrophil mediated damage to lung endo- thelial cells in vitro and disappears in the process, Free Radic. Biol. Med., 1989, 6, 457-466.         [ Links ]

41 O. Olagunju, P.A. Siegel, R. Olojo and R.H. Simoyi, Oxyhalogen-sulfur chemistry: kinetics and mechanism of oxidation of N-acetylthiourea by chlorite and chlorine dioxide, J. Phys. Chem. A, 2006,110, 2396-410.         [ Links ]

42 C.R. Chinake and R.H. Simoyi, New experimental-data on the chlorite-thiourea reaction, J. Phys. Chem,. 1993, 97, 11569-11570.         [ Links ]

43 R.K. Singh, T. Mandal, N. Balsubramanian, et al., Histone deacetylase activators: N-acetylthioureas serve as highly potent and isozyme selective activators for human histone deacetylase-8 on a fluorescent substrate, Bioorg. Med. Chem. Lett., 2011, 21, 5920-5923.         [ Links ]

44 R.H. Simoyi, I. R. Epstein and K. Kustin, Systematic design of chemical oscillators. 88. Kinetics and mechanism of the oxidation of thiourea by bromate in acidic solution, J. Phys. Chem., 1994, 98, 551-557.         [ Links ]

45 T. Chigwada, W. Mbiya, K. Chipiso and R.H. Simoyi, S-oxygenation of thiocarbamides V: oxidation of tetramethylthiourea by chlorite in slightly acidic media, J. Phys. Chem. A 2014,118, 5903-5914.         [ Links ]

46 R.M. Noyes, Chemical oscillations and instabilities. 39. A generalized mechanism for bromate-driven oscillators by bromide, J. Am. Chem. Soc. 1980,102, 4644-649.         [ Links ]

47 T.R Chigwada, E. Chikwana, T. Ruwona, O. Olagunju and R.H. Simoyi, S-Oxygenation of thiocarbamides. 3. Nonlinear kinetics in the oxidation of trimethylthiourea by acidic bromate, J. Phys. Chem. A, 2007, 111, 11552-11561.         [ Links ]

 

 

Received 22 August 2015
Revised 11 October 2015
Accepted 14 October 2015

 

 

* To whom correspondence should be addressed. E-mail: rsimoyi@pdx.edu

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License